European equities traded in the US as American depositary receipts were rallying late Friday morning, rising 0.98% to 1,367.20 on the S&P Europe Select ADR Index, but were still down 1.4% for the week.
From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and semiconductor company Sequans Communications (SQNS), which rose 5.8% and 3.3%, respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which were up 2.4% and 2.1%, respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm BioNTech (BNTX), which fell 4.7% and 1.4%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and internet advertising firm Criteo (CRTO), which were off 0.8% and 0.7%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Silence Therapeutics (SLN), which increased 5.4% and 3.6%, respectively. They were followed by financial services company Lloyds Banking Group (LYG) and biopharmaceutical company Amarin Corporation (AMRN), which rose 2.9% and 2.8%, respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB), which fell 3.4%, followed by biopharmaceutical company Akari Therapeutics (AKTX) and cruise line operator Carnival (CUK) were off 0.2% and 0.1%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。